Ditchcarbon
  • Contact
  1. Organizations
  2. Vericel Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Vericel Corporation Sustainability Profile

Company website

Vericel Corporation, a leading player in the regenerative medicine industry, is headquartered in the United States. Founded in 1989, the company has made significant strides in developing innovative cell-based therapies, particularly for patients with severe skin injuries and cartilage damage. Vericel's core products, including Epicel® and MACI®, are distinguished by their ability to harness the body’s own cells to promote healing, setting them apart in the competitive landscape of advanced therapeutics. With a strong presence in the US and expanding operations in key international markets, Vericel has established itself as a pioneer in the field. The company’s commitment to research and development has led to notable achievements, including FDA approvals that underscore its market position. Vericel continues to drive advancements in regenerative medicine, aiming to improve patient outcomes and redefine treatment paradigms.

DitchCarbon Score

How does Vericel Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

19

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Vericel Corporation's score of 19 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

19%

Let us know if this data was useful to you

Vericel Corporation's reported carbon emissions

Vericel Corporation, headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures for kg CO2e. Additionally, there are no documented reduction targets or climate pledges at this time. The company does not inherit emissions data from any parent organisation, ensuring that all information is directly related to Vericel Corporation itself. As such, the organisation's climate commitments and initiatives remain unspecified, reflecting a need for further transparency and action in addressing carbon emissions and sustainability efforts.

How Carbon Intensive is Vericel Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vericel Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Vericel Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vericel Corporation is in US, which has a low grid carbon intensity relative to other regions.

Vericel Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Vericel Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Vericel Corporation's Emissions with Industry Peers

Integra lifesciences

US
•
Health and social work services (85)
Updated 9 days ago

Osiris Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 26 days ago

CONMED Corporation

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 16 days ago

Wright Medical Group N.V.

GB
•
Health and social work services (85)
Updated about 1 month ago

Acelity L.P. Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy